SSE Health Care ETF (SHA:510660)

China · Delayed Price · Currency is CNY

2.506

-0.006 (-0.24%)

Sep 22, 2026, 4:00 PM EDT

Assets	120.92M
Expense Ratio	0.60%
PE Ratio	23.14
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	-8.74%

Volume	4,414,300
Open	2.514
Previous Close	2.512
Day's Range	2.487 - 2.536
52-Week Low	2.085
52-Week High	2.800
Beta	0.27
Holdings	67
Inception Date	Mar 28, 2013

About 510660

SSE Health Care ETF is an exchange traded fund launched and managed by China Asset Management Co., Ltd. The fund invests in the public equity markets of China. It seeks to invest in the stocks of companies operating in the health care sector. The fund invests in the stocks of companies across all market capitalizations. It seeks to replicate the performance of the SSE Health Care Index, by investing in the stocks of companies as per their weightings in the index. SSE Health Care ETF was formed on March 28, 2013 and is domiciled in China.

Asset Class Equity

Category Total Market

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 510660

Provider ChinaAMC

Index Tracked SSE Medical and Health Industry Index - CNY - Benchmark TR Gross

Performance

510660 had a total return of -8.74% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.52%.

Top 10 Holdings

57.62% of assets

Name	Symbol	Weight
WuXi AppTec Co., Ltd.	603259	17.82%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd	600276	15.50%
Shanghai United Imaging Healthcare Co., Ltd.	688271	5.01%
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.	600436	3.28%
BeOne Medicines AG	688235	3.02%
Shanghai Allist Pharmaceuticals Co., Ltd.	688578	2.95%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	600196	2.83%
iRay Group	688301	2.56%
RemeGen Co., Ltd.	688331	2.33%
Sichuan Biokin Pharmaceutical Co.,Ltd.	688506	2.32%

View More Holdings